Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.

[1]  A. Lucas,et al.  Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborati , 1993, The Journal of clinical investigation.

[2]  M. Osterholm,et al.  Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. , 1992, JAMA.

[3]  K. Edwards,et al.  Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. , 1992, The Journal of pediatrics.

[4]  E. Rothstein,et al.  Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines. , 1991, American journal of diseases of children.

[5]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[6]  D. Sack,et al.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. , 1991, The New England journal of medicine.

[7]  E. Rothstein,et al.  Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children. , 1991, The Journal of pediatrics.

[8]  E. Vittinghoff,et al.  Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children , 1991, The Pediatric infectious disease journal.

[9]  J. C. Parke,et al.  Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age. , 1991, The Journal of pediatrics.

[10]  J. Eskola,et al.  Antibody responses to four Haemophilus influenzae type b conjugate vaccines. , 1991, American journal of diseases of children.

[11]  R. Ellis,et al.  Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccines in Infant Rhesus Monkeys , 1991, Pediatric Research.

[12]  P. Mäkelä,et al.  A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. , 1990, The New England journal of medicine.

[13]  J. Donnelly,et al.  Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. , 1990, Journal of immunology.

[14]  P. Byass,et al.  Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. , 1990, Pediatrics.

[15]  D. Granoff,et al.  Variability in the Functional Activity of Vaccine-Induced Antibody to Haemophilus influenzae Type b , 1990, Pediatric Research.

[16]  D. Smith,et al.  Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants. , 1990, Pediatrics.

[17]  D. Granoff,et al.  Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. , 1988, The Journal of pediatrics.

[18]  D. Granoff,et al.  Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. , 1987, Pediatrics.

[19]  D. Granoff,et al.  Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. , 1987, The Journal of pediatrics.

[20]  D. Granoff,et al.  IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN , 1986, The Lancet.

[21]  D. Granoff,et al.  Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. , 1986, The Journal of infectious diseases.

[22]  D. Granoff,et al.  Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak. , 1986, Pediatrics.

[23]  J. Shiloach,et al.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates , 1984, Infection and immunity.

[24]  D. Smith,et al.  Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. , 1973, Pediatrics.